Assessment of Crohn's Disease Activity: Magnetic Resonance Enterography in Comparison with Clinical and Endoscopic Evaluations.


Journal

Journal of gastrointestinal and liver diseases : JGLD
ISSN: 1842-1121
Titre abrégé: J Gastrointestin Liver Dis
Pays: Romania
ID NLM: 101272825

Informations de publication

Date de publication:
01 Jun 2019
Historique:
received: 11 06 2019
entrez: 18 6 2019
pubmed: 18 6 2019
medline: 7 3 2020
Statut: epublish

Résumé

Crohn's disease (CD) is a chronic inflammatory condition characterized by continuous mucosal damage and ongoing wound healing of the intestines. The fibrinolytic system is involved in early parts of the wound healing process. Fibrin is a key mediator of primary blood clot formation and is formed by cross-linking of fibrinogen. To gain insights into the dynamics of wound healing in CD patients we investigated the conversion of fibrinogen into fibrin by the pro-peptide FPA, the amount of factor XIII cross-linked fibrin and total fibrin clot. Serum samples of 35 CD patients, 15 non-inflammatory bowel disease (non-IBD) patients and 39 age-matched healthy controls were analyzed for three novel neo-epitope markers: D-fragment and D-dimer, reflecting the degradation of total fibrin clot and factor XIII cross-linked fibrin, as well as FPA, reflecting synthesis of fibrin. Crohn's disease patients had a significantly lower D-dimer level (p=0.0001) compared to healthy controls. Crohn's disease and non-IBD patients had a significantly higher level of FPA (p<0.0001) and D-fragment/D-dimer ratio (p<0.0001 and p=0.02). FPA, D-dimer and D-fragment/D-dimer ratio could distinguish CD patients from healthy controls with area under the curve of 0.92 (95% CI 0.83-0.97), 0.78 (95% CI 0.67-0.87) and 0.85 (95% CI 0.75-0.93), respectively. Wound healing parameters were clearly changed in CD patients. FPA levels were higher in CD patients as compared to healthy controls, indicating more ongoing wound healing. D-dimer levels were lower in CD patients than in healthy controls, indicating impaired wound healing due to poor quality of factor XIII cross-linked fibrin and clot resolution.

Identifiants

pubmed: 31204402
doi: 10.15403/jgld-183
doi:

Substances chimiques

Fibrin Fibrinogen Degradation Products 0
fibrin fragment D 0
fibrinogen D fragment 0

Types de publication

Comparative Study Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

213-224

Auteurs

Laura Maria Minordi (LM)

Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC di Radiologia, Dipartimento di Scienze Radiologiche, Radioterapiche ed Ematologiche, Rome, Italy. lauramaria.minordi@policlinicogemelli.it.

Luigi Larosa (L)

Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC di Radiologia, Dipartimento di Scienze Radiologiche, Radioterapiche ed Ematologiche, Rome, Italy.

Alfredo Papa (A)

Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC di Medicina Interna e Gastroenterologia, Dipartimento di Scienze Gastroenterologiche, Endocrino-Metaboliche e Nefro-Urologiche, Rome, Italy; Università Cattolica del Sacro Cuore, Roma, IUOC Istituto di Patologia Speciale Medica e Semeiotica Medica.

Veronica Bordonaro (V)

Università Cattolica del Sacro Cuore, Istituto di Radiologia. Rome, Italy.

Loris Lopetuso (L)

Università Cattolica del Sacro Cuore, Roma, IUOC Istituto di Patologia Speciale Medica e Semeiotica Medica, Italy.

Grainne Holleran (G)

Department of Clinical Medicine, School of Medicine, Trinity College Dublin, 2 Dublin, Ireland.

Antonio Gasbarrini (A)

Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC di Medicina Interna e Gastroenterologia, Dipartimento di Scienze Gastroenterologiche, Endocrino-Metaboliche e Nefro-Urologiche, Rome, Italy; Università Cattolica del Sacro Cuore, Roma, IUOC Istituto di Patologia Speciale Medica e Semeiotica Medica.

Riccardo Manfredi (R)

Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC di Radiologia, Dipartimento di Scienze Radiologiche, Radioterapiche ed Ematologiche, Rome, Italy; Department of Clinical Medicine, School of Medicine, Trinity College Dublin, 2 Dublin, Ireland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH